Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;188(2):391-7.
doi: 10.1016/j.juro.2012.04.006. Epub 2012 Jun 13.

Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage

Kirk A Keegan  1 , Clayton W Schupp, Karim Chamie, Nicholas J Hellenthal, Christopher P Evans, Theresa M Koppie
Affiliations

Histopathology of surgically treated renal cell carcinoma: survival differences by subtype and stage

Kirk A Keegan et al. J Urol. 2012 Aug.

Abstract

Purpose: Previous studies of the impact of renal cell carcinoma histopathology on survival are conflicting and generally limited to institutional analyses. Thus, we determined the role of renal cell carcinoma histopathology on the stage specific survival rate in a large population based cohort.

Materials and methods: We used the 2000 to 2005 National Cancer Institute SEER (Surveillance, Epidemiology and End Results) database to identify 17,605 patients who underwent surgery for renal cell carcinoma and met study inclusion criteria. Patients were stratified by histological subtype (clear cell, papillary, chromophobe, collecting duct and sarcomatoid differentiation) and pathological stage. We performed Cox proportional hazard modeling and Kaplan-Meier survival analysis to determine overall and cancer specific survival.

Results: Patients with papillary and chromophobe pathology were less likely to present with T3 or greater disease (17.6% and 16.9%, respectively) while patients with collecting duct and sarcomatoid variants were more likely to present with T3 or greater disease (55.7% and 82.8%, respectively) compared to those with clear cell histology (p <0.001). On multivariate analysis histology was significantly associated with overall and cancer specific survival. Patients with chromophobe pathology had improved survival (HR 0.56, 95% CI 0.40-0.78) while those with collecting duct and sarcomatoid variants had worse survival (HR 2.07, 95% CI 1.44-2.97 and 2.26, 95% CI 1.93-2.64, respectively).

Conclusions: Renal cell carcinoma histological subtype predicts overall and cancer specific survival. Patients with collecting duct and sarcomatoid variants of renal cell carcinoma have poor survival, even those who present with low stage disease. These data suggest inherent differences in renal cell carcinoma biology and may ultimately form the basis of future histologically targeted therapies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Cancer specific survival.
Figure 2
Figure 2
Overall survival.
See this image and copyright information in PMC

References

    1. Kovacs G, Akhtar M, Beckwith BJ, et al. The Heidelberg classification of renal cell tumours. J Pathol. 1997;183:131. - PubMed
    1. de Peralta-Venturina M, Moch H, Amin M, et al. Sarcomatoid differentiation in renal cell carcinoma: a study of 101 cases. Am J Surg Pathol. 2001;25:275. - PubMed
    1. Ro J, Ayala A, Sella A, et al. Sarcomatoid renal cell carcinoma: clinicopathologic study of 42 cases. Cancer. 1987;59:516. - PubMed
    1. Ljungberg B, Alamdari FI, Stenling R, et al. Prognostic significance of the Heidelberg classification of renal cell carcinoma. Eur Urol. 1999;36:565. - PubMed
    1. Moch H, Gasser T, Amin MB, et al. Prognostic utility of the recently recommended histological classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors. Cancer. 2000;89:604. - PubMed

Publication types

MeSH terms